Reducing the levels of airway glycan ligands for Siglec-F diminishes the natural pro-apoptotic pathway for controlling airway eosinophilia and is associated with reduced ST3Gal-III function in the lungs, resulting in exaggerated eosinophilic airway inflammation [36]. This evidence concerns the gene ST3GAL3 and inflammation.